Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Inquiry Memorial
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Support and FAQs
    • NHS Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Hepatitis C Testing
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

The topic of AIDS was discussed in a meeting of directors of the Scottish National Blood Transfusion Service and haemophilia centre directors. In the meeting, Dr Cash drew attention to recent articles in The Observer and The Lancet and circulated a MMWR extract.

Published on: 27 September, 2024

The topic of Factor 9 concentrates was discussed in a meeting of directors of the Scottish National Blood Transfusion Service and haemophilia centre directors. It was reported that studies of heat treatment, to reduce the hepatitis risk, were currently underway using Supernine.

Published on: 27 September, 2024

In a haemophilia reference centre directors meeting, it was noted that "there were some concern that the haemophilic population of the U.K. who had received American concentrates might be at risk" of AIDS. It was agreed that Dr Craske should draw up a form for the reporting of cases and to arrange for it to be circulated to all haemophilia centre directors.

Published on: 27 September, 2024

A meeting of the Haemostasis Club took place where Professor Jeanne Luscher presented on AIDS and set out treatment recommendations from the US.

Published on: 27 September, 2024

Drs Craske, Rizza and Bloom wrote to all haemophilia centre directors inviting them to report possible cases of AIDS.

Published on: 27 September, 2024

Dr Craske authored a report on AIDS, referring to the possibility that the agent for AIDS "might be present in the plasma pools used to prepare commercial factor VIII and IX concentrate manufactured from donor plasma collected in the U.S.A.".

Published on: 27 September, 2024

Dr Craske authored a guidance document for identifying possible cases of AIDS.

Published on: 27 September, 2024

A Form was drafted regarding U.K. Haemophilia Centre Directors Hepatitis Working Party's Surveillance of Possible Cases of the AIDS

Published on: 27 September, 2024

Kevin Slater was 20 years old when his AIDS symptoms were first identified and just 22 years old when he died in 1985.

Published on: 27 September, 2024

In his statement to the Haemophilia Society, Professor Bloom stated that he was "unaware of any proven case" of AIDS among people with haemophilia in the UK.

Published on: 27 September, 2024

The Communicable Disease Surveillance Centre ("CDSC") published a weekly report observing Kevin Slater's case as"This is the first report of AIDS in a patient with haemophilia in the United Kingdom known to CDSC."

Published on: 27 September, 2024

Dr Nicol Spence Galbraith (CDSC), notified the DHSS regarding the report of AIDS in a patient with haemophilia in the United Kingdom.

Published on: 27 September, 2024

Dr Galbraith (PHLS) concluded in a letter to Dr Ian Field (DHSS) that all products made from blood donated in the USA after 1978 should be withdrawn from use.

Published on: 27 September, 2024

Dr Walford, wrote a memo to Dr Field regarding Dr Galbraith's conclusion on the withdrawal of all blood products from donated blood in the USA.

Published on: 27 September, 2024

Professor Bloom stated in a letter to the haemophilia centres directors "I hope that it will be possible rapidly to vary the Product Licence for relevant imported products to take account of these recent developments."

Published on: 27 September, 2024

The Council of Europe issued its recommendations which included avoiding, the use of coagulation factor concentrates prepared from large plasma pools and informing people with haemophilia of the potential health hazards of haemotherapy and the possibilities of minimising these risks.

Published on: 27 September, 2024

At the Hepatitis Working Party's meeting the position in relation to the occurence of cases of AIDS in haemophilia A patients treated with commercial factor concentrates was reviewed. It was stated that there had been two cases of the syndrome in the UK.

Published on: 27 September, 2024

Dr Delamore stated that he appreciated that the freeze-dried preparations were much more suitable for home treatment, which he now hoped to institute in selected cases.

Published on: 27 September, 2024

Except for two patients on a period of prophylaxis with commercial concentrate noted below, all 10 other severe haemophiliac participants were treated with NHS freeze-dried factor-VIII concentrate prepared by the Lister Institute Laboratories.

Published on: 27 September, 2024

Inquiry publishes financial annual report

Published on: 08 September, 2022

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2252
  • Page 2253
  • Page 2254
  • Page 2255
  • Current page 2256
  • Page 2257
  • Page 2258
  • Page 2259
  • Page 2260
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.